ARTICLE | Clinical News
Forxiga dapagliflozin regulatory update
March 31, 2014 7:00 AM UTC
Japan's Ministry of Health, Labor and Welfare (MHLW) approved an NDA for AstraZeneca's Forxiga dapagliflozin to treat Type II diabetes. In December, AZ and Ono Pharmaceutical Co. Ltd. (Tokyo:4528, Os...